NOS1 and Behcet disease: In conclusion, our findings indicate that alterations in SDMA, citrulline, ornithine, and NOS activity in the unaffected offspring of BD patients may contribute to BD pathophysiology and serve as peripheral biomarkers in this high-risk group.